ANAU 100 MG TBL FLM 28 II

What is the maximum co-payment for ANAU?

If the insurance company contributes, the maximum co-payment is 601,86 Kč. The maximum pharmacy price is 844,61 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does ANAU have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

242,75 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Sitagliptin je hrazen v kombinaci s metforminem a/nebo sulfonylureou nebo v kombinaci s thiazolidindiony u pacientů, u nichž použití maximálních tolerovaných dávek zmíněných léčiv po dobu alespoň 3 měsíců společně s režimovými opatřeními nevedlo k uspokojivé kompenzaci diabetu definované jako hladina HbA1c nižší než 53 mmol/mol. Nedojde-li k prokazatelnému zlepšení kompenzace diabetu o 7 % či vyššímu poklesu hladiny HbA1c při kontrole po 6 měsících léčby, sitagliptin není dále hrazen. V kombinaci s inzulinem nejsou léčivé přípravky s obsahem sitagliptinu hrazeny.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe ANAU?

Prescription is not conditional on a medical specialization.

What is the composition of ANAU?

Monohydrát sitagliptin-hydrochloridu (113,38 mg), sitagliptin (100 mg), neznámá látka s kódem 3755, hydrogenfosforečnan vápenatý, neznámá látka s kódem 14679, magnesium-stearát, polyvinylalkohol, oxid titaničitý, neznámá látka s kódem 4077, ointmentek, žlutý oxid železitý, červený oxid železitý. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to ANAU?

The medicine belongs to ATC group A10BH01 – SITAGLIPTIN. Medicines with the same active substance can be found here.

Who manufactures ANAU?

Heaton k.s., Praha (CZ)

Is the medicine in shortage?

The latest report from the manufacturer is from 21. 1. 2026. Production was terminated with effect from 31. 3. 2026. The manufacturer lists medicines with the following code as a potential substitute: